{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:38Z","timestamp":1761560018739,"version":"3.37.3"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0129419","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T17:30:47Z","timestamp":1434130247000},"page":"e0129419","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Fernando","family":"P\u00e9rez-Roca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Rodrigo-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Celeste","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-\u00c1ngel","family":"Mart\u00edn-Piedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Carriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Isabel","family":"Ortiz-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indalecio","family":"S\u00e1nchez-Montesinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Alaminos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"HA Quigley","year":"2006","journal-title":"The British journal of ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2147\/OPTH.S76053","article-title":"The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies","volume":"8","author":"NM Radcliffe","year":"2014","journal-title":"Clinical ophthalmology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"MC Leske","year":"2003","journal-title":"Archives of ophthalmology"},{"key":"ref4","first-page":"63","article-title":"Pharmacotherapy of glaucoma. Journal of ocular pharmacology and therapeutics: the official journal of the","volume":"31","author":"D Schmidl","year":"2015","journal-title":"Association for Ocular Pharmacology and Therapeutics"},{"issue":"Suppl1","key":"ref5","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.survophthal.2008.08.012","article-title":"Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences","volume":"53","author":"GW Bean","year":"2008","journal-title":"Survey of ophthalmology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archopht.1987.01060080114039","article-title":"Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha","volume":"105","author":"K Crawford","year":"1987","journal-title":"Archives of ophthalmology"},{"issue":"Suppl1","key":"ref7","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"CB Toris","year":"2008","journal-title":"Survey of ophthalmology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00055735-200004000-00008","article-title":"The mechanism of action of prostaglandins on uveoscleral outflow","volume":"11","author":"U Schachtschabel","year":"2000","journal-title":"Current opinion in ophthalmology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02850114","article-title":"Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension","volume":"20","author":"MB Abelson","year":"2003","journal-title":"Advances in therapy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/108076803762718088","article-title":"Conjunctival hyperemia and the use of topical prostaglandins in glaucoma and ocular hypertension","volume":"19","author":"RM Feldman","year":"2003","journal-title":"Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(02)01980-3","article-title":"Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost","volume":"135","author":"WC Stewart","year":"2003","journal-title":"American journal of ophthalmology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/exer.1999.0819","article-title":"Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines","volume":"70","author":"R Dutkiewicz","year":"2000","journal-title":"Exp Eye Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/exer.1999.0760","article-title":"Effect of prostaglandins A(2), E(1), F(2 alpha)and latanoprost on cultured human iridal melanocytes","volume":"70","author":"DN Hu","year":"2000","journal-title":"Exp Eye Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/exer.1999.0718","article-title":"Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue","volume":"69","author":"NG Lindquist","year":"1999","journal-title":"Exp Eye Res"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bolivar G, Sanchez-Barahona C, Teus M, Castejon MA, Paz-Moreno-Arrones J, Gutierrez-Ortiz C, et al. Effect of topical prostaglandin analogues on corneal hysteresis. Acta ophthalmologica. 2015. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1111\/aos.12689\" xlink:type=\"simple\">10.1111\/aos.12689<\/ext-link><\/comment>","DOI":"10.1111\/aos.12689"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","article-title":"Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension","volume":"132","author":"PA Netland","year":"2001","journal-title":"American journal of ophthalmology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","article-title":"Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term","volume":"111","author":"C Baudouin","year":"2004","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","article-title":"Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery","volume":"112","author":"DC Broadway","year":"1994","journal-title":"Archives of ophthalmology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bjo.2008.138768","article-title":"Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride","volume":"92","author":"H Liang","year":"2008","journal-title":"The British journal of ophthalmology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"RJ Noecker","year":"2004","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02713680801971857","article-title":"In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line","volume":"33","author":"E Brasnu","year":"2008","journal-title":"Current eye research"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1167\/iovs.05-0776","article-title":"In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells","volume":"46","author":"JM Guenoun","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000055579","article-title":"Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits","volume":"32","author":"PJ Pisella","year":"2000","journal-title":"Ophthalmic Res"},{"key":"ref24","first-page":"619","article-title":"Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells","volume":"40","author":"M De Saint Jean","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/02713683.2011.578781","article-title":"Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells","volume":"36","author":"F Brignole-Baudouin","year":"2011","journal-title":"Current eye research"},{"key":"ref26","first-page":"446","article-title":"In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells. Korean journal of ophthalmology","volume":"27","author":"EJ Kim","year":"2013","journal-title":"KJO"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713683.2011.626909","article-title":"The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo","volume":"37","author":"P Pellinen","year":"2012","journal-title":"Current eye research"},{"key":"ref28","first-page":"394","article-title":"Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines","volume":"14","author":"E Brasnu","year":"2008","journal-title":"Molecular vision"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000360776","article-title":"Mitotic stability of small supernumerary marker chromosomes: a study based on 93 immortalized cell lines","volume":"142","author":"H Spittel","year":"2014","journal-title":"Cytogenetic and genome research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1535370213503274","article-title":"An early and late cytotoxicity evaluation of lidocaine on human oral mucosa fibroblasts","volume":"239","author":"AC Oliveira","year":"2014","journal-title":"Experimental biology and medicine"},{"key":"ref31","first-page":"745","article-title":"The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit","volume":"26","author":"B Sjoquist","year":"1998","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2014recent advances","volume":"17","author":"CL Bourlais","year":"1998","journal-title":"Progress in retinal and eye research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e72459","DOI":"10.1371\/journal.pone.0072459","article-title":"Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro","volume":"8","author":"S Michee","year":"2013","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"PJ Pisella","year":"2002","journal-title":"The British journal of ophthalmology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"N Jaenen","year":"2007","journal-title":"European journal of ophthalmology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"C Baudouin","year":"2010","journal-title":"Progress in retinal and eye research"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10384-009-0754-8","article-title":"Effects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprost","volume":"54","author":"S Yamazaki","year":"2010","journal-title":"Japanese journal of ophthalmology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5301\/ejo.5000270","article-title":"Preservative-free treatment in glaucoma: who, when, and why","volume":"23","author":"I Stalmans","year":"2013","journal-title":"European journal of ophthalmology"},{"key":"ref39","first-page":"1967","article-title":"Latanoprost in the treatment of glaucoma","volume":"8","author":"A Alm","year":"2014","journal-title":"Clinical ophthalmology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0129419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T17:10:50Z","timestamp":1566839450000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0129419"}},"subtitle":[],"editor":[{"given":"Che John","family":"Connon","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0129419","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}